The Korean journal of internal medicine

  • 제32권3호
  • /
  • Pages.439-441
  • /
  • 2017
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Oxidative stress: link between hypertension and diabetes

  • Moon, Jun Sung (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Won, Kyu Chang (Department of Internal Medicine, Yeungnam University College of Medicine)
  • 투고 : 2017.04.07
  • 심사 : 2017.04.26
  • 발행 : 2017.05.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep 2012;14:160-166. https://doi.org/10.1007/s11883-012-0227-2
  2. Ramalingam L, Menikdiwela K, LeMieux M, et al. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochim Biophys Acta 2016 Aug 4 [Epub]. https://doi.org/10.1016/j.bbadis.2016.07.019.
  3. Manucha W, Ritchie B, Ferder L. Hypertension and insulin resistance: implications of mitochondrial dysfunction. Curr Hypertens Rep 2015;17:504. https://doi.org/10.1007/s11906-014-0504-2
  4. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002;143:2975-2985. https://doi.org/10.1210/endo.143.8.8931
  5. Moon JS, Karunakaran U, Elumalai S, et al. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells. J Diabetes Complications 2017;31:21-30. https://doi.org/10.1016/j.jdiacomp.2016.09.001
  6. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008;29:351-366. https://doi.org/10.1210/er.2007-0023
  7. Lupi R, Del Guerra S, Bugliani M, et al. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 2006;154:355-361. https://doi.org/10.1530/eje.1.02086
  8. NAVIGATOR Study Group, McMurray JJ, Holman RR, et al. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477-1490. https://doi.org/10.1056/NEJMoa1001121
  9. van der Zijl NJ, Moors CC, Goossens GH, Hermans MM, Blaak EE, Diamant M. Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial. Diabetes Care 2011;34:845-851. https://doi.org/10.2337/dc10-2224
  10. Kurata A, Nishizawa H, Kihara S, et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006;70:1717-1724. https://doi.org/10.1038/sj.ki.5001810
  11. Wei Y, Sowers JR, Nistala R, et al. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 2006;281:35137-35146. https://doi.org/10.1074/jbc.M601320200
  12. Macconi D, Perico L, Longaretti L, et al. Sirtuin3 dysfunction is the key determinant of skeletal muscle insulin resistance by angiotensin II. PLoS One 2015;10:e0127172. https://doi.org/10.1371/journal.pone.0127172
  13. Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 1999;31:275-281. https://doi.org/10.1006/jmcc.1998.0867
  14. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA. Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens 2004;17:743-748. https://doi.org/10.1016/j.amjhyper.2004.05.013
  15. Hirooka Y, Kimura Y, Sagara Y, Ito K, Sunagawa K. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Clin Exp Hypertens 2008;30:267-276. https://doi.org/10.1080/10641960802071000
  16. Aslam S, Santha T, Leone A, Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int 2006;70:2109-2115. https://doi.org/10.1038/sj.ki.5001983
  17. Kim HJ, Han SJ, Kim DJ, et al. Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study. Korean J Intern Med 2017;32:497-504. https://doi.org/10.3904/kjim.2015.404
  18. Mihalj M, Tadzic R, Vcev A, Rucevic S, Drenjancevic I. Blood pressure reduction is associated with the changes in oxidative stress and endothelial activation in hypertension, regardless of antihypertensive therapy. Kidney Blood Press Res 2016;41:721-735. https://doi.org/10.1159/000450562
  19. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003;361:2017-2023. https://doi.org/10.1016/S0140-6736(03)13637-9

피인용 문헌

  1. Enteric glial cell activation protects enteric neurons from damage due to diabetes in part via the promotion of neurotrophic factor release vol.30, pp.10, 2018, https://doi.org/10.1111/nmo.13368
  2. Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/5575545